MINI FUTURE LONG - QUEST DIAGNOSTICS | Market Closed - Boerse Frankfurt Warrants 20:50:38 31/05/2024 BST | ||
| 4.32 EUR | +2.61% |
|
| 1 month | -0.70% | ||
| 3 months | +42.14% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 4.25 | +0.95% |
| 30/05/24 | 4.21 | +1.94% |
| 29/05/24 | 4.13 | -1.43% |
| 28/05/24 | 4.19 | -4.99% |
| 27/05/24 | 4.41 | +0.46% |
Real-time Boerse Frankfurt Warrants
Last update May 31, 2024 at 08:50 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PZ0YZA |
| ISIN | DE000PZ0YZA8 |
| Date issued | 03/11/2023 |
| Strike | 93.98 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.05 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.78 € |
|---|---|
| Lowest since issue | 2.85 € |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
142
USD
Average target price
147
USD
Spread / Average Target
+3.54%
- Stock Market
- Certificates
- Certificat
